- Home
- SGMT vs OGI Comparison
SGMT vs OGI Comparison
Compare SGMT & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- OGI
- Stock Information
- Founded
- SGMT 2006
- OGI 2013
- Country
- SGMT United States
- OGI Canada
- Employees
- SGMT N/A
- OGI N/A
- Industry
- SGMT
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- SGMT
- OGI Health Care
- Exchange
- SGMT Nasdaq
- OGI Nasdaq
- Market Cap
- SGMT 128.5M
- OGI 142.5M
- IPO Year
- SGMT 2023
- OGI N/A
- Fundamental
- Price
- SGMT $3.72
- OGI $1.03
- Analyst Decision
- SGMT Strong Buy
- OGI
- Analyst Count
- SGMT 6
- OGI 0
- Target Price
- SGMT $25.67
- OGI N/A
- AVG Volume (30 Days)
- SGMT 315.0K
- OGI 734.0K
- Earning Date
- SGMT 03-12-2025
- OGI 05-13-2025
- Dividend Yield
- SGMT N/A
- OGI N/A
- EPS Growth
- SGMT N/A
- OGI N/A
- EPS
- SGMT N/A
- OGI N/A
- Revenue
- SGMT N/A
- OGI $115,451,336.00
- Revenue This Year
- SGMT N/A
- OGI $50.11
- Revenue Next Year
- SGMT N/A
- OGI $16.16
- P/E Ratio
- SGMT N/A
- OGI N/A
- Revenue Growth
- SGMT N/A
- OGI N/A
- 52 Week Low
- SGMT $2.39
- OGI $0.96
- 52 Week High
- SGMT $7.38
- OGI $2.37
- Technical
- Relative Strength Index (RSI)
- SGMT 44.81
- OGI 37.65
- Support Level
- SGMT $3.70
- OGI $1.04
- Resistance Level
- SGMT $4.24
- OGI $1.16
- Average True Range (ATR)
- SGMT 0.23
- OGI 0.06
- MACD
- SGMT 0.04
- OGI 0.02
- Stochastic Oscillator
- SGMT 45.70
- OGI 35.00
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.